There has been shown benefit on lowering blood pressure, improving blood cholesterol, often leading to less medication needed for the treatment of these conditions, she added
No severe side effects occurred, and there were no signs of fat rebound during the 4-week placebo follow-up
In the SUSTAIN 8 study, patients with T2DM exhibited a lean mass decrease of 2.3 kg alongside a total weight loss of 5.3 kg, resulting in 43.4% of weight loss attributable to lean mass, while the ratio of lean mass to total mass increased by 1.2% from the baseline [111]
"We originally began building this tracker for Ro patients but knew that our scaled supply data and tech expertise positioned us to help all patients (whether Ro patient or not) navigate the shortage and have a greater chance of finding the GLP-1 medications they need." The GLP-1 Supply Tracker leverages Ro's proprietary, nationwide supply data as well as user-generated reports along with the latest information from the FDA's Drug Shortage List
Over 90% of tirzepatide-treated patients reverted to normoglycemia, compared with under 60% with placebo
23.Newsome JS